Radiotheranostic targeting of colorectal CSCs using Prominin 1 (PROM1; known as CD133) and CD44 monoclonal antibodies labeled with radioodine led to a significant inhibition of tumor growth and prolonged mean survival of xenografted mice injected with HT29 CRC cell line (75). This evidence concerns the gene PROM1 and colorectal carcinoma.